Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study-Reference-Cited by-同舟云学术

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

Published:2012-11 Issue:5 Volume:143 Page:1218-1226.e2
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sandborn William J.,Travis Simon,Moro Luigi,Jones Richard,Gautille Theres,Bagin Robert,Huang Michael,Yeung Phil,Ballard E. David

Funder

Abbott Laboratories

Bristol-Myers Squibb

Genentech

GlaxoSmithKline

Janssen

Millennium Pharmaceuticals

Novartis

Pfizer

Procter & Gamble

Shire Pharmaceuticals

UCB Pharma

Abbott

Pfizer Inc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Ulcerative colitis;Ordas;Lancet,2012

2. Cortisone in ulcerative colitis;Truelove;BMJ,1955

3. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee;Kornbluth;Am J Gastroenterol,2010

4. European evidence-based consensus on the management of ulcerative colitis: current management;Travis;J Crohns Colitis,2008

5. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease;Lichtenstein;Gastroenterology,2006

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

2. Unraveling the mechanism of malancao in treating ulcerative colitis: A multi-omics approach;World Journal of Clinical Cases;2024-06-16

3. The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis;Frontiers in Gastroenterology;2024-06-03

4. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

5. Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey;Journal of Clinical Medicine;2024-04-24